Logo image
IRO Home Research units Researcher Profiles
Sign in
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
Journal article   Open access   Peer reviewed

Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults

Shannon L Risacher, Brenna C McDonald, Eileen F Tallman, John D West, Martin R Farlow, Fredrick W Unverzagt, Sujuan Gao, Malaz Boustani, Paul K Crane, Ronald C Petersen, …
JAMA neurology, Vol.73(6), pp.721-732
06/01/2016
DOI: 10.1001/jamaneurol.2016.0580
PMCID: PMC5029278
PMID: 27088965
url
https://doi.org/10.1001/jamaneurol.2016.0580View
Published (Version of record) Open Access

Abstract

The use of anticholinergic (AC) medication is linked to cognitive impairment and an increased risk of dementia. To our knowledge, this is the first study to investigate the association between AC medication use and neuroimaging biomarkers of brain metabolism and atrophy as a proxy for understanding the underlying biology of the clinical effects of AC medications.
Magnetic Resonance Imaging Brain - diagnostic imaging Apolipoprotein E4 - genetics Cognition Disorders - diagnostic imaging Cognition Disorders - chemically induced Humans Fluorodeoxyglucose F18 - metabolism Male Positron-Emission Tomography Brain - metabolism Aged, 80 and over Female Cholinergic Antagonists - adverse effects Memory Disorders - diagnostic imaging Atrophy - diagnostic imaging Cognition Disorders - pathology Proportional Hazards Models Cognition Disorders - genetics Brain - drug effects Neuropsychological Tests Brain - pathology Aged Atrophy - chemically induced Executive Function - drug effects Memory Disorders - chemically induced

Details

Logo image